Carlsbad, CA, United States of America

Patrick S Dillon


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Patrick S. Dillon

Introduction

Patrick S. Dillon is an innovative inventor based in Carlsbad, California. He has made significant contributions to the field of genomics through his research and patent in the area of Streptococcus pneumoniae polynucleotides. Dillon has dedicated his career to advancing scientific understanding and applications related to genetic materials.

Latest Patents

Dillon holds a patent for "Streptococcus pneumoniae polynucleotides and sequences." This invention provides valuable polynucleotide sequences of the genome, along with the corresponding polypeptide sequences encoded by these sequences. Additionally, it includes vectors and hosts that incorporate the polynucleotides, as well as assays and various applications. Notably, the invention also offers information regarding polynucleotide and polypeptide sequences stored on computer-readable media, alongside computer-based systems that facilitate their practical use.

Career Highlights

Patrick S. Dillon has established a notable career at Human Genome Sciences, Inc., where he focuses on groundbreaking research in human genetics and genomics. His work has made a lasting impact in the scientific community, particularly in identifying and utilizing genomic sequences for various applications.

Collaborations

During his career, Dillon has collaborated with esteemed colleagues, including Charles A. Kunsch and Gil H. Choi. These partnerships have enabled him to enhance his work and contribute to collective advancements in the field of genomics.

Conclusion

Patrick S. Dillon continues to be a prominent figure in the world of genetic research and innovation. His patent on Streptococcus pneumoniae polynucleotides represents a significant stride forward in understanding the genetic foundations of important pathogens. Through his work at Human Genome Sciences, Inc. and collaborations with other talented professionals, Dillon is poised to make further contributions to the field and improve therapeutic approaches for health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…